Related Experiment Video
Updated: May 22, 2026

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits (Oryctolagus cuniculus)
Published on: July 31, 2021
The further and future evolution of the New Zealand Immunisation Schedule
1Ropata Medical Centre, Lower Hutt, New Zealand. Stewart_christine@mac.com
Abstract:
MeNZB was introduced to control meningococcal disease in New Zealand in 2004 and routine use ceased in 2008. In that year, two new vaccines were added to the New Zealand Childhood Immunisation Schedule, pneumococcal and human papilloma virus, and two more, varicella and rotavirus, have been recommended but not funded. By comparison, in the 16 years prior to 2006 only one new vaccine was introduced, Haemophilus influenzae type B. Coverage is improving and is now around 90%, making timeliness an important target and supplementary strategies for controlling pertussis of greater importance. A personal view of each of these vaccines is provided in this article.
Insights
New Zealand
Area of Science:
- Public Health
- Immunisation Policy
- Vaccinology
Background:
- Meningococcal B (MeNZB) vaccine use in New Zealand (2004-2008).
- Introduction of pneumococcal and human papillomavirus vaccines in 2008.
- Comparison of vaccine introduction rates pre- and post-2006.
Purpose of the Study:
- To provide an overview of vaccine introductions in New Zealand.
- To discuss the evolving childhood immunisation schedule.
- To highlight the importance of timely immunisation and pertussis control.
Main Methods:
- Review of vaccine introduction timelines and immunisation schedule changes.
- Analysis of vaccine coverage trends.
- Discussion of supplementary strategies for disease control.
Main Results:
- Significant increase in new vaccine introductions post-2006.
- Current childhood immunisation coverage approaching 90%.
- Timeliness and pertussis control identified as key priorities.
Conclusions:
- New Zealand's immunisation landscape has rapidly evolved.
- Focus is shifting towards timely administration and specific disease control.
- Personal perspectives on key vaccines are offered.
More Related Videos
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Vaccines
Microorganisms in Medicine and Therapeutics
Infectious Diseases and Their Occurrence
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

